Roman Nawroth

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Cell Proliferation

Protein Protein

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sebastian Johannes Schober, Caroline Schoening, Jennifer Eck, Charlotte Middendorf, Julia Lutsch, Pia Knoch, Anna Josefine von Ofen, Hendrik Gassmann, Melanie Thiede, Julia Hauer, Andreas Kolk, Klaus Mantwill, Juergen E Gschwend, Stefan E G Burdach, Roman Nawroth, Uwe Thiel, Per Sonne Holm
The oncolytic adenovirus XVir-N-31 joins forces with CDK4/6 inhibition augmenting innate and adaptive antitumor immunity in Ewing sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jana Koch, Sebastian Johannes Schober, Sruthi V Hindupur, Caroline Schöning, Florian Gerhard Klein, Klaus Mantwill, Maximilian Ehrenfeld, Ulrike Schillinger, Timmy Hohnecker, Pan Qi, Katja Steiger, Michaela Aichler, Jürgen E Gschwend, Roman Nawroth, Per Sonne Holm
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus. Nature communications 13 (1) (2022)
Anuja Sathe, Géraldine Chalaud, Immanuel Oppolzer, Kit Yeng Wong, Margarita von Busch, Sebastian C Schmid, Zhichao Tong, Margitta Retz, Juergen E Gschwend, Wolfgang A Schulz, Roman Nawroth
Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy. PloS one 13 (1) (2018)